VaramirStart free · no cardSign in
MLYS as of Oct 31 · 22:54 ET
MLYSNasdaqPharmaceutical Preparations

Mineralys Therapeutics, Inc. · Brief

Next report

8 days

Nov 9 · after closeest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
0 of 8≥ implied
avg implied
±18.8%
avg realized
±4.3%
Nov 12 '24±28.0%▼−10.32%×0.37
Feb 12 '25±53.7%▲+10.04%×0.19
May 12 '25±9.3%▲+1.20%×0.13
Aug 12 '25±13.2%▲+0.37%×0.03
Q3 FY25±11.0%▲+5.87%×0.53
Q1 FY26±10.5%▼−2.96%×0.28
May 6 '26±15.2%▼−2.56%×0.17
Q2 FY26±9.5%▼−1.02%×0.11
quarterimplied−55%0+55%realized×
Q2 FY26±9.5%▼−1.02%×0.11
May '26±15.2%▼−2.56%×0.17
Q1 FY26±10.5%▼−2.96%×0.28
Q3 FY25±11.0%▲+5.87%×0.53
Aug '25±13.2%▲+0.37%×0.03
May '25±9.3%▲+1.20%×0.13
2 older reports
Feb '25±53.7%▲+10.04%×0.19
Nov '24±28.0%▼−10.32%×0.37
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 9 report · est.

Bull2 of 3

4tracked funds holding MLYSN-PORT · Aug 31 '26
226managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2

4 of 24of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
0.71%of State Street SPDR S&P Biotech ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

MLYS report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 298-KMaterial agreement: Termination Agreement and Payment Obligation Agreement with Tanabe Pharma Corporation.Source
Oct 26impliedImplied move: ±15.5% into Nov 9 earnings (Oct 26 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.